Literature DB >> 19028470

Prenatal exposure of rats to nicotine causes persistent alterations of nicotinic cholinergic receptors.

Allison B Gold1, Ashleigh B Keller, David C Perry.   

Abstract

We examined for immediate and persistent changes in nAChRs in cerebral cortex, thalamus and striatum of male rats caused by prenatal exposure to nicotine from gestational day 3 to postnatal day 10 (PN10), and how such exposure affected the responses of adolescents to subsequent nicotine challenge. Receptor numbers were assessed by [(3)H]epibatidine binding and receptor function was measured by acetylcholine-stimulated (86)Rb efflux (cerebral cortex and thalamus) and nicotine-stimulated dopamine release (striatum). Immediate effects of prenatal nicotine, assessed in PN10 animals, were not detected for any parameter. A subsequent 14 day nicotine exposure in adolescence revealed persistent changes caused by prenatal nicotine exposure. Nicotine exposure in adolescents caused up-regulation of binding in all three regions; however, this up-regulation was lost in thalamus from animals prenatally exposed to nicotine. Nicotine exposure in adolescents caused decreased nicotine-stimulated dopamine release in striatum; this effect was lost in animals prenatally exposed to nicotine. Comparison of parameters in PN10 and PN42 rats revealed developmental changes in the CNS cholinergic system. In thalamus, binding increased with age, as did the proportion of (86)Rb efflux with high sensitivity to acetylcholine. In cortex, binding also increased with age, but there was no change in total (86)Rb efflux, and the proportion of high to low sensitivity efflux declined with age. Nicotine-stimulated striatal dopamine release (both total and alpha-conotoxin MII-resistant release) increased with age in naïve animals, but not in those prenatally exposed to nicotine. These findings demonstrate that prenatal exposure to nicotine causes alterations in nAChRs and in their regulation by nicotine that persist into adolescence. These changes may play a role in the increased risk for nicotine addiction observed in adolescent offspring of smoking mothers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028470      PMCID: PMC2866508          DOI: 10.1016/j.brainres.2008.10.076

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  40 in total

1.  Prenatal nicotine exposure alters the response to nicotine administration in adolescence: effects on cholinergic systems during exposure and withdrawal.

Authors:  Yael Abreu-Villaça; Frederic J Seidler; Charlotte A Tate; Mandy M Cousins; Theodore A Slotkin
Journal:  Neuropsychopharmacology       Date:  2004-05       Impact factor: 7.853

2.  Adult and periadolescent rats differ in expression of nicotinic cholinergic receptor subtypes and in the response of these subtypes to chronic nicotine exposure.

Authors:  Menahem B Doura; Allison B Gold; Ashleigh B Keller; David C Perry
Journal:  Brain Res       Date:  2008-04-04       Impact factor: 3.252

3.  Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions.

Authors:  J A Trauth; F J Seidler; E C McCook; T A Slotkin
Journal:  Brain Res       Date:  1999-12-18       Impact factor: 3.252

4.  Agonist regulation of rat alpha 3 beta 4 nicotinic acetylcholine receptors stably expressed in human embryonic kidney 293 cells.

Authors:  E L Meyer; Y Xiao; K J Kellar
Journal:  Mol Pharmacol       Date:  2001-09       Impact factor: 4.436

5.  Characterization of nicotinic agonist-induced [(3)H]dopamine release from synaptosomes prepared from four mouse brain regions.

Authors:  Sharon R Grady; Karen L Murphy; Jian Cao; Michael J Marks; J Michael McIntosh; Allan C Collins
Journal:  J Pharmacol Exp Ther       Date:  2002-05       Impact factor: 4.030

6.  Subsets of acetylcholine-stimulated 86Rb+ efflux and [125I]-epibatidine binding sites in C57BL/6 mouse brain are differentially affected by chronic nicotine treatment.

Authors:  Michael J Marks; Peter P Rowell; Jian-Zhe Cao; Sharon R Grady; Sarah E McCallum; Allan C Collins
Journal:  Neuropharmacology       Date:  2004-06       Impact factor: 5.250

7.  Binding and functional activity of nicotinic cholinergic receptors in selected rat brain regions are increased following long-term but not short-term nicotine treatment.

Authors:  Henry N Nguyen; Bruce A Rasmussen; David C Perry
Journal:  J Neurochem       Date:  2004-07       Impact factor: 5.372

8.  Nicotine is a neurotoxin in the adolescent brain: critical periods, patterns of exposure, regional selectivity, and dose thresholds for macromolecular alterations.

Authors:  Yael Abreu-Villaça; Frederic J Seidler; Charlotte A Tate; Theodore A Slotkin
Journal:  Brain Res       Date:  2003-07-25       Impact factor: 3.252

9.  Nicotine administration to rats: methodological considerations.

Authors:  L C Murrin; J R Ferrer; W Y Zeng; N J Haley
Journal:  Life Sci       Date:  1987-04-27       Impact factor: 5.037

10.  Subunit composition and pharmacology of two classes of striatal presynaptic nicotinic acetylcholine receptors mediating dopamine release in mice.

Authors:  Outi Salminen; Karen L Murphy; J Michael McIntosh; John Drago; Michael J Marks; Allan C Collins; Sharon R Grady
Journal:  Mol Pharmacol       Date:  2004-06       Impact factor: 4.436

View more
  28 in total

Review 1.  Nicotinic acetylcholine receptors: upregulation, age-related effects and associations with drug use.

Authors:  W E Melroy-Greif; J A Stitzel; M A Ehringer
Journal:  Genes Brain Behav       Date:  2015-12-23       Impact factor: 3.449

2.  Exploring alternate processes contributing to the association between maternal smoking and the smoking behavior among young adult offspring.

Authors:  Arielle S Selya; Lauren S Wakschlag; Lisa C Dierker; Jennifer S Rose; Donald Hedeker; Robin J Mermelstein
Journal:  Nicotine Tob Res       Date:  2013-06-12       Impact factor: 4.244

3.  Neonatal nicotine exposure increases excitatory synaptic transmission and attenuates nicotine-stimulated GABA release in the adult rat hippocampus.

Authors:  Joanne C Damborsky; William H Griffith; Ursula H Winzer-Serhan
Journal:  Neuropharmacology       Date:  2014-06-17       Impact factor: 5.250

4.  Effects of chronic nicotine on heteromeric neuronal nicotinic receptors in rat primary cultured neurons.

Authors:  Ermelinda Lomazzo; Gregory P Hussmann; Barry B Wolfe; Robert P Yasuda; David C Perry; Kenneth J Kellar
Journal:  J Neurochem       Date:  2011-09-01       Impact factor: 5.372

5.  Risk factors for adolescent smoking: parental smoking and the mediating role of nicotine dependence.

Authors:  Arielle S Selya; Lisa C Dierker; Jennifer S Rose; Donald Hedeker; Robin J Mermelstein
Journal:  Drug Alcohol Depend       Date:  2012-02-25       Impact factor: 4.492

6.  The interaction of the Chrna5 D398N variant with developmental nicotine exposure.

Authors:  H C O'Neill; C R Wageman; S E Sherman; S R Grady; M J Marks; J A Stitzel
Journal:  Genes Brain Behav       Date:  2018-04-17       Impact factor: 3.449

7.  Prenatal nicotine exposure decreases the release of dopamine in the medial frontal cortex and induces atomoxetine-responsive neurobehavioral deficits in mice.

Authors:  Tursun Alkam; Takayoshi Mamiya; Nami Kimura; Aya Yoshida; Daisuke Kihara; Yuki Tsunoda; Yuki Aoyama; Masayuki Hiramatsu; Hyoung-Chun Kim; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2017-03-23       Impact factor: 4.530

8.  Assessment of the Relationship Between Smoking and Depression in Pregnant Women.

Authors:  Şerif Kurtuluş; Remziye Can; Zafer Hasan Ali Sak
Journal:  J Immigr Minor Health       Date:  2021-06

9.  Early exposure to nicotine during critical periods of brain development: Mechanisms and consequences.

Authors:  Andrew M Smith; Linda P Dwoskin; James R Pauly
Journal:  J Pediatr Biochem       Date:  2010

10.  Evaluation of cognitive behaviors in young offspring of C57BL/6J mice after gestational nicotine exposure during different time-windows.

Authors:  Tursun Alkam; Hyoung-Chun Kim; Takayoshi Mamiya; Kiyofumi Yamada; Masayuki Hiramatsu; Toshitaka Nabeshima
Journal:  Psychopharmacology (Berl)       Date:  2013-06-23       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.